Raiffeisen Switzerland Cooperative Share Price

Certificat

BJCRCH

CH1100459390

Market Closed - Bid/Ask 08:50:00 07/06/2024 pm IST After market 08:45:00 pm
99.6 CHF +0.11% Intraday chart for Raiffeisen Switzerland Cooperative 99.75 +0.15%
Current month+0.49%
1 month+1.23%
Date Price Change
07/24/07 99.6 +0.11%
06/24/06 99.49 +0.17%
05/24/05 99.32 +0.09%
04/24/04 99.23 +0.12%

Delayed Quote Swiss Exchange

Last update June 07, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Raiffeisen Switzerland B.V.
BJCRCH
ISINCH1100459390
Date issued 14/10/2021
Strike 355.6 CHF
Maturity 14/10/2024 (126 Days)
Parity 0.36 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 99.6 CHF
Lowest since issue 88.93 CHF
Spread 8 CHF
Spread %0.80%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
239.7 CHF
Average target price
277.5 CHF
Spread / Average Target
+15.78%
Consensus
  1. Stock Market
  2. Certificates
  3. BJCRCH Certificat